"Kim Stanley Robinson - Forty Signs of Rain" - читать интересную книгу автора (Robinson Kim Stanley)

response: still reviewingтАФdo not publish yet.

тАЬThey want to find out what they can patent in it,тАЭ Brian said.

тАЬThey wonтАЩt let us publish until we have a delivery method and a patent,тАЭ Marta predicted.

тАЬBut that may never happen!тАЭ Leo cried. тАЬItтАЩs good work, itтАЩs interesting! It could help make a big
breakthrough!тАЭ

тАЬThatтАЩs what they donтАЩt want,тАЭ Brian said.

тАЬThey donтАЩt want a big breakthrough unless itтАЩs our big breakthrough.тАЭ

тАЬShit.тАЭ

This had happened before, but Leo had never gotten used to it. Sitting on results, doing private science,
secret scienceтАФit went against the grain. It wasnтАЩt science as he understood it, which was a matter of
finding out things and publishing them for all to see and test, critique, put to use.

But it was getting to be standard operating procedure. Security in the building remained intense; even
e-mails out had to be checked for approval, not to mention laptops, briefcases, and boxes leaving the
building. тАЬYou have to check in your brain when you leave,тАЭ as Brian put it.

тАЬFine by me,тАЭ Marta said.

тАЬI just want to publish,тАЭ Leo insisted grimly.

тАЬYouтАЩd better find a targeted delivery method if you want to publish that particular paper, Leo.тАЭ

So they continued to work on the Urtech method. The new experiments slowly yielded their results. The
volumes and dosages had sharp parameters on all sides. The тАЬtourniquet injectionтАЭ method did not
actually insert very many copy DNAs into the subject animalsтАЩ endothelial cells, and a lot of what was
inserted was damaged by the process, and later flushed out of the body.
In short, the Maryland method was still an artifact.

By now, however, enough time had passed that Derek could pretend that the whole thing had never
happened. It was a new financial quarter; there were other fish to fry, and for now the pretense could be
plausibly maintained that it was a work in progress rather than a total bust. It wasnтАЩt as if anyone else had
solved the targeted nonviral delivery problem, after all. It was a hard problem. Or so Derek could say, in
all truth, and did so whenever anyone was inconsiderate enough to bring the matter up. Whiners on the
companyтАЩs website chat room could be ignored as always.

Analysts on Wall Street, however, and in the big pharmaceuticals, and in relevant venture capital firms,
could not be ignored. And while they werenтАЩt saying anything directly, investment money started to go
elsewhere. Torrey PinesтАЩ stock fell, and because it was falling it fell some more, and then more again.
Biotechs were fluky, and so far Torrey Pines had not generated any potential cash cows. They remained
a start-up. Fifty-one million dollars was being swept under the rug, but the big lump in the rug gave it
away to anyone who remembered what it was.

No. Torrey Pines Generique was in trouble.